ABT-199 based therapies to treat neuroblastoma

Active Project Grant Awarded Last action

Award ID
R01CA215610
Recipient
Awarding agency
Obligated
$2,930,667

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date 79% complete
Originally
Place of performance
Richmond, VA 23219, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $492,086
Amendment $492,086
Amendment $505,898
Amendment $0
Amendment ABT-199 based therapies to treat neuroblastoma - high-risk neuroblastoma accounts for the second most pediatric cancer deaths. Amplification of mycn accounts… $0
Amendment $359,846
Amendment $349,049
Amendment $35,985
Amendment $323,861
Original award $371,856

Subawards

Subrecipient Amount Awarded
Universitat De Barcelona ABT-199 based therapies to treat neuroblastoma $81,745

Quick answers

Who received award R01CA215610?

R01CA215610 was awarded to Virginia Commonwealth University by National Cancer Institute (National Institutes of Health) on April 1, 2017.

How much is award R01CA215610 worth?

$2,930,667 has been obligated on R01CA215610.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award